Effects of a Smartphone-Supported Daily Walking Intervention on Psychological Well-Being and Body Composition in Adults With Cardiometabolic Disease
DAILY-WALK
Psychological Benefits of Increased Daily Walking Precede Meaningful Changes in BodyComposition in Adults With Cardiometabolic Disease
1 other identifier
interventional
419
1 country
1
Brief Summary
This study evaluated whether a three-month smartphone-supported daily walking intervention could improve physical activity, psychological well-being, and body composition in adults with cardiometabolic disease. Participants had cardiovascular disease and/or type 2 diabetes and used the Walk15 smartphone platform to monitor daily step count. The intervention aimed to increase daily walking by approximately 1,000 steps per day through individualized step goals, self-monitoring, and digital feedback. Outcomes were assessed before and after the intervention and included daily step count, body composition, handgrip strength, sleep duration, eating behaviors, subjective well-being, vigor, stress, anxiety, health, and happiness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2024
CompletedFirst Submitted
Initial submission to the registry
June 23, 2026
CompletedFirst Posted
Study publicly available on registry
June 29, 2026
CompletedJune 29, 2026
June 1, 2026
3 months
June 23, 2026
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Daily Step Count
Daily step count was assessed using the Walk15 smartphone platform, which synchronized step-count data from participants' smartphones and wearable devices. Change was calculated as the difference between baseline daily step count and post-intervention daily step count.
Baseline to 3 months
Study Arms (1)
Smartphone-Supported Daily Walking Intervention Arm Type
EXPERIMENTALParticipants received a three-month smartphone-supported walking intervention delivered through the Walk15 platform. Individualized step goals were established based on baseline activity levels, and participants were encouraged to increase daily walking by approximately 1,000 steps per day. Daily step counts were monitored using smartphone-connected wearable devices and synchronized with the Walk15 platform.
Interventions
Participants received a three-month smartphone-supported walking intervention delivered through the Walk15 platform. Individualized step goals were established based on baseline daily step counts. Participants were encouraged to increase daily walking by approximately 1,000 steps per day, progressing gradually during the first month. Daily step counts were monitored using smartphone-connected wearable devices and synchronized with the Walk15 platform. Participants received feedback through the platform to support adherence. No dietary modifications, weight-loss program, or structured exercise training were prescribed.
Eligibility Criteria
You may qualify if:
- Adults aged 20 to 65 years Physician-confirmed diagnosis of cardiovascular disease and/or type 2 diabetes mellitus verified through medical records Medical clearance from the treating physician confirming that participation in a walking-based physical activity program was safe and appropriate Ability to use the Walk15 smartphone platform or smartphone-connected wearable device for step-count monitoring Written informed consent provided before enrollment
You may not qualify if:
- Severe mobility limitations Acute medical conditions Psychiatric disorders requiring pharmacological treatment Inability to complete baseline or post-intervention assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klaipėda University
Klaipėda, Lithuania
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Albertas Skurvydas, dr
KU
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 23, 2026
First Posted
June 29, 2026
Study Start
March 18, 2024
Primary Completion
June 18, 2024
Study Completion
June 18, 2024
Last Updated
June 29, 2026
Record last verified: 2026-06